Amicus Therapeutics Shares Gap Down Time to Sell?
FOLD Stock | USD 9.46 0.10 1.07% |
About 54% of Amicus Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Amicus Therapeutics suggests that many traders are impartial. The current market sentiment, together with Amicus Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Amicus Therapeutics stock news signals to limit their universe of possible portfolio assets.
Amicus |
Shares of Amicus Therapeutics, Inc. gapped down prior to trading on Tuesday . The stock had previously closed at 9.66, but opened at 9.37. Amicus Therapeutics shares last traded at 9.45, with a volume of 191,497 shares traded. Analysts Set New Price Targets A number of analysts have recently issued
Read at thelincolnianonline.com
Amicus Therapeutics Current Investor Sentiment
Panic Vs Confidence
46
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amicus Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amicus Therapeutics.
News SentimentNeutral | Hype SentimentNeutral | Insider SentimentDisposing |
Amicus Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amicus Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amicus Therapeutics Historical Investor Sentiment
Investor biases related to Amicus Therapeutics' public news can be used to forecast risks associated with an investment in Amicus. The trend in average sentiment can be used to explain how an investor holding Amicus can time the market purely based on public headlines and social activities around Amicus Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amicus Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amicus Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amicus Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Amicus Therapeutics.
Amicus Therapeutics Maximum Pain Price Across January 17th 2025 Option Contracts
Amicus Therapeutics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Amicus Therapeutics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Amicus Therapeutics' options.
Amicus Therapeutics Fundamental Analysis
We analyze Amicus Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amicus Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amicus Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Amicus Therapeutics is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Amicus Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amicus Therapeutics stock to make a market-neutral strategy. Peer analysis of Amicus Therapeutics could also be used in its relative valuation, which is a method of valuing Amicus Therapeutics by comparing valuation metrics with similar companies.
Peers
Amicus Therapeutics Related Equities
AGIO | Agios Pharm | 2.22 | ||||
ARVN | Arvinas | 2.01 | ||||
MREO | Mereo BioPharma | 0.80 | ||||
BMRN | Biomarin Pharmaceutical | 0.71 | ||||
DNLI | Denali Therapeutics | 0.33 | ||||
RVMD | Revolution Medicines | 0.20 | ||||
ARGX | Argenx NV | 0.1 | ||||
EWTX | Edgewise Therapeutics | 0.08 | ||||
INCY | Incyte | 0.08 | ||||
DAWN | Day One | 1.61 | ||||
RARE | Ultragenyx | 1.78 | ||||
HRMY | Harmony Biosciences | 1.85 | ||||
CRNX | Crinetics Pharmaceuticals | 1.86 | ||||
CYTK | Cytokinetics | 2.35 | ||||
LEGN | Legend Biotech | 2.35 | ||||
DYN | Dyne Therapeutics | 3.35 | ||||
INBX | Inhibrx | 3.42 | ||||
BPMC | Blueprint Medicines | 3.96 | ||||
KURA | Kura Oncology | 4.77 | ||||
MLYS | Mineralys Therapeutics, | 13.71 |
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |